Evidence map›Paper›PMID 27300766›Full record

ArticleEndocrinology2016

Butyrylcholinesterase Deficiency Promotes Adipose Tissue Growth and Hepatic Lipid Accumulation in Male Mice on High-Fat Diet.

Vicky Ping Chen, Yang Gao, Liyi Geng, Michael B Stout, Michael D Jensen, Stephen Brimijoin

Open access · bronzeAbstract read
In one paragraph

Article in Endocrinology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 51 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Associations of Butyrylcholinesterase Activity and Lipid-Related Indices with Obesity in Thai Children.International journal of environmental research and public health · 2025
    Article
  9. Article
  10. Elevated Cholinesterase Activity and the Metabolic Syndrome-Dissecting Fatty Liver, Insulin Resistance and Dysglycaemia.Liver international : official journal of the International Association for the Study of the Liver · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Vicky Ping ChenDepartment of Molecular Pharmacology and Experimental Therapeutics, Kogod Center on Aging, Mayo Clinic, and Minnesota Nutrition and Obesity Center, Rochester, Minnesota 55905.
Yang GaoDepartment of Molecular Pharmacology and Experimental Therapeutics, Kogod Center on Aging, Mayo Clinic, and Minnesota Nutrition and Obesity Center, Rochester, Minnesota 55905.
Liyi GengDepartment of Molecular Pharmacology and Experimental Therapeutics, Kogod Center on Aging, Mayo Clinic, and Minnesota Nutrition and Obesity Center, Rochester, Minnesota 55905.
Michael B StoutDepartment of Molecular Pharmacology and Experimental Therapeutics, Kogod Center on Aging, Mayo Clinic, and Minnesota Nutrition and Obesity Center, Rochester, Minnesota 55905.
Michael D JensenDepartment of Molecular Pharmacology and Experimental Therapeutics, Kogod Center on Aging, Mayo Clinic, and Minnesota Nutrition and Obesity Center, Rochester, Minnesota 55905.
Stephen BrimijoinDepartment of Molecular Pharmacology and Experimental Therapeutics, Kogod Center on Aging, Mayo Clinic, and Minnesota Nutrition and Obesity Center, Rochester, Minnesota 55905.
Minnesota Oncology · USMayo Clinic · US

Funding

Cocaine hydrolase gene therapy for cocaine abuse (DPI)DP1DA031340 · NIDA · MAYO CLINIC ROCHESTER · PI BRIMIJOIN, WILLIAM STEPHEN · 2010 to 2014
$3.9M
Mechanisms of metabolic, inflammatory and healthspan enhancement by 17a-estradiolK99AG051661 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI STOUT, MICHAEL B · 2016 to 2017
$278k
NIA NIH HHS K99 AG051661NIDA NIH HHS DP1 DA031340
6 · The paper itself

Abstract

Despite numerous reports of relationships between weight gain and butyrylcholinesterase (BChE), this enzyme's role in the genesis of obesity remains unclear, but recent research points to strong links with ghrelin, the "hunger hormone." The availability of BChE knockout (KO) mice provides an opportunity to clarify the causal relationship between BChE and obesity onset. We now find that young KO mice have abnormally high plasma ghrelin levels that slowly decline during long-term high-fat feeding and ultimately drop below those in wild-type mice. On such a diet, the KO mice gained notably more weight, more white fat, and more hepatic fat than wild-type animals. In addition to a greater burden of hepatic triglycerides, the livers of these KO mice show distinctly higher levels of inflammatory markers. Finally, their energy expenditure proved to be lower than in wild-type mice despite similar activity levels and increased caloric intake. A gene transfer of mouse BChE with adeno-associated virus vector restored nearly all aspects of the normal phenotype. Our results indicate that BChE strongly affects fat metabolism, has an important impact on fat accumulation, and may be a promising tool for combating obesity.

Indexed as

Diet, High-FatAdipose TissueAdiposityAnimalsApneaButyrylcholinesteraseHEK293 CellsHumansLipid MetabolismLiverMaleMetabolism, Inborn ErrorsMiceMice, Inbred C57BLMice, KnockoutOrgan SizeButyrylcholinesterase

Identifiers

PMID27300766
PMCPMC4967128
OpenAlexW2440072910

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.